Tag Archives: Novel

Health standards organizations help codify novel coronavirus info

As part of the global effort to manage and contain the coronavirus response, two global health standards organizations have introduced new content. Regenstrief Institute and SNOMED International, are supporting care teams globally to code and track SARS-CoV-2 testing and COVID-19 cases, and by extension support clinicians and researchers in their efforts to address its containment.… Read More »

Novel drug targets tumor growth in advanced kidney cancer

Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease. Researchers from Dana-Farber Cancer Institute report a response rate of 24 percent across all risk categories of patients given an oral first-in-class agent that targets hypoxia inducible factor (HIF) 2-a, which promotes… Read More »